Thermo Fisher Scientific introduced new solutions for enhancing research workflows during ASMS 2024. Key products included advanced mass spectrometry instruments and a new UHPLC system designed to improve analytical capabilities and efficiency. These innovations aim to support the journey from discovery to clinical application in precision medicine.
Anaheim, California — Thermo Fisher Scientific rolled out a slate of new solutions aimed at streamlining research workflows during the American Society for Mass Spectrometry (ASMS) Conference. This event is a significant gathering for mass spectrometry and related fields, and the company highlighted tools designed to enhance productivity in the realms of discovery, translational research, and clinical applications.
The company unveiled advanced mass spectrometry and chromatography instruments, enhancing analytical capabilities and integration. August Specht, who oversees R&D in chromatography and mass spectrometry at Thermo Fisher, emphasized the importance of tailored solutions for specific application areas. He remarked that these new offerings are designed to take findings from compounds into clinical research, effectively bridging research gaps.
Among the standout products is the Thermo Scientific Orbitrap™ Astral™ mass spectrometer, which complements the power of the new Stellar™ MS, a system that takes translational omics research further than before. This Stellar MS enhances biomarker verification with rapid and sensitive quantitation, achieving remarkable sensitivity—10 times more for five times as many compounds compared to past technologies. It’s quite the game-changer for researchers.
To further meet the growing demand in liquid chromatography-mass spectrometry (LC-MS), the new Thermo Scientific Vanquish™ Neo ultra-high performance liquid chromatography (UHPLC) system was introduced. This system boasts a Tandem Direct Injection workflow that ramps up sample throughput significantly, as in, nearly 70% more samples per day! That’s a huge leap for proteomics labs, making it possible to work efficiently with high-throughput mass spectrometers like the Orbitrap Astral and Stellar MS.
In addition to individual instruments, Thermo Fisher rolled out three built-for-purpose editions of its Orbitrap Ascend Editions Tribrid™ mass spectrometers. They’ve introduced variations tailored to applications like MultiOmics, Structural Biology, and BioPharma. Each edition carries new hardware features that enhance sustainable performance and enable greater versatility in quantifying smaller samples. This step forward opens new doors for scientists aiming for breakthroughs in research.
Later this year, the launch of Thermo Scientific TMTpro 32plex Label Reagents will elevate performance to new heights, facilitating the analysis of up to 32 samples in one LC-MS injection. This innovation is pivotal for areas that require in-depth coverage—think chemoproteomics and single-cell proteomics.
As labs increasingly focus on seamless operations, Thermo Fisher emphasizes the importance of software integration. Their Ardia™ platform is a game plan for connecting various data, applications, and instruments in one secure ecosystem. New enhancements to the platform emphasize security and connectivity, providing improved support for the already noted Orbitrap Astral and Stellar MS.
Notably, with updates to Compound Discoverer 3.4 and the introduction of third-party Skyline.ms support, labs have options to manage and share data like never before. This level of integration stands to dissolve silos in data handling, allowing scientists to gather insights into emerging diagnostics and therapies more swiftly.
For additional details on the cutting-edge solutions revealed at ASMS 2024, interested parties can visit www.thermofisher.com/ASMS.
Thermo Fisher Scientific Inc. stands as a frontrunner in scientific services, reporting over $40 billion in annual revenue. Their mission is to empower customers to improve health, safety, and community wellness, whether in life science research or the development of transformative therapies. With its extensive suite of brands—including Thermo Scientific, Applied Biosystems, and Invitrogen—Thermo Fisher is unwavering in its support for advancements in science.
For media inquiries, contact Laura Bright at Thermo Fisher Scientific at [email protected].
In summary, Thermo Fisher Scientific has unveiled several innovative solutions at ASMS 2024 designed to enhance research workflows in precision medicine. Their advancements in mass spectrometry, UHPLC systems, and integrated software underscore the commitment to improving analytical insights while streamlining processes for researchers. The company’s guided focus on built-for-purpose technology fosters breakthroughs in scientific discovery and progression into clinical applications.
Original Source: www.businesswire.com